Polish construction boom seen lasting to 2040; firms urged to seize last chance
Published 1 d ago4 sourcesEvidence: Reported
Poland's lengthy regulatory procedures for clinical trial approval are driving sponsors to faster countries, costing an estimated 311 additional trials annually and hundreds of millions of złotych in economic activity. The claim is based on a Polish media report and reflects a competitive disadvantage in the EU clinical research market. This matters as it signals a structural drag on Poland's life-sciences sector and potential investment.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Entities
Published 1 d ago4 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 23 h ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 6 h ago1 sourceEvidence: Reported
Published 15 h ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported